Inspire Medical Soars 29% on Medicare Payment Boost
Inspire Medical Systems stock jumps after CMS approves major Medicare payment increase for sleep apnea procedures, effective 2026. Stifel upgrades to Buy.
/ 913 items
#Healthcare↓
Arcellx Stock Dips on Kelonia's Early CAR-T Data: Analyst Calls Reaction "Overdone"
Guggenheim analyst says Arcellx stock decline is overdone after competitor Kelonia released early Phase 1 CAR-T therapy data. Maintains Buy rating despite market pressure.
Evercore ISI Begins Coverage of Beam Therapeutics With Bullish Outlook
Evercore ISI initiates coverage of Beam Therapeutics (BEAM) with an Outperform rating and $35 price target, citing promising early data for BEAM-302 in treating AATD and highlighting key data expected in Q1 2026.
Bayer's Stroke Prevention Drug Shows Promise, Reviving Hope for New Blood Clot Treatment Class
Bayer's asundexian succeeds in Phase 3 stroke prevention trial, becoming first FXIa inhibitor to show positive results and potentially opening door for safer blood clot medications.
Key Pharma Stock Updates: Merck, BeOne, MeiraGTx, MannKind, and Fulcrum
Wells Fargo upgrades Merck to Overweight; Truist and H.C. Wainwright initiate coverage on BeOne Medicines, MeiraGTx, MannKind, and Fulcrum with Buy ratings and promising price targets.
White House to Propose 2-Year Obamacare Subsidy Extension with New Restrictions
White House plans to unveil health policy framework extending ACA subsidies for two years while adding income caps and minimum premium requirements to address expiring benefits.